Dalansay, Maria Teresa C.
HRN: 08-53-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2023
CIPROFLOXACIN 500MG (TAB)
09/12/2023
09/18/2023
PO
500mg
BID
AGE
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes